Novum Peptides

Research use only

Before you enter

Please confirm the following before browsing Novum Peptides.

Adults onlyYou must be 18 years or older to enter.

Laboratory research onlyOur products are not for human or veterinary use.

We’ll remember your confirmation on this browser where storage is available.

Novum Peptides · For laboratory research only

Semax: molecular identity and research context

Identify Semax and distinguish selected rat brain studies from a small human performance study without turning either into a general cognitive claim.

Semax literature uses several ACTH-related names and spans molecular measurements, brain injury models and human performance tasks. Reading those papers together requires more than collecting positive conclusions. This reference identifies the peptide and follows three evidence routes, keeping their questions and limits visible.

Recognise the sequence behind the ACTH terminology

Sudarkina and colleagues identify Semax as Met-Glu-His-Phe-Pro-Gly-Pro, written MEHFPGP. Their paper uses ACTH(4–7)PGP, indicating the ACTH-derived segment followed by Pro-Gly-Pro.Sudarkina and colleagues — Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion (opens in a new tab)

Names encountered in this research map
TermHow to read it
SemaxName used for MEHFPGP in these studies
ACTH(4–7)PGPFragment-derived sequence with the PGP extension
ACTH analogueA relationship to ACTH, not a statement that full-length ACTH was tested
Sudarkina and colleagues — Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion (opens in a new tab)

Keep the explicit sequence beside the paper title in your notes. An ACTH-related keyword can retrieve studies on other fragments, so a search result is not automatically a Semax experiment.

The sequence listed on Novum’s product page is an identity anchor. Matching that sequence does not establish equivalence to the preparation, formulation or exposure used in an older publication.

Read transcript and protein findings as separate observations

Medvedeva and colleagues’ 2017 rat focal-ischaemia study compared gene-expression responses associated with Semax and the shorter PGP peptide. The reported immune-response patterns differed between those materials.Medvedeva and colleagues — Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats (opens in a new tab)

This comparison matters because sharing a sequence segment does not make two experimental agents interchangeable. A summary should retain which preparation produced each expression pattern instead of attributing all findings to the shared tail.

In 2021, Sudarkina and colleagues measured selected proteins after transient cerebral artery occlusion in rats. They reported changes involving CREB, MMP-9, c-Fos and JNK, with differences between sampled brain regions.Sudarkina and colleagues — Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion (opens in a new tab)

Those tissue measurements are relevant to proposed injury-response mechanisms. They do not directly measure a person’s memory, nor do they establish that every observed molecular change is necessary for a functional effect.

Include the human paper without enlarging its claim

Kaplan and colleagues’ 1996 paper reports human operator-performance and EEG experiments. The operator component involved 16 men, divided between Semax and placebo; the authors reported task-performance differences. Other components examined electrical brain activity.Kaplan and colleagues — Synthetic ACTH analogue Semax displays nootropic-like activity in humans (opens in a new tab)

This is human evidence, so describing the entire Semax literature as animal-only would be inaccurate. Its presence also does not justify describing broad cognitive enhancement as established.

The particular participants, tasks and observation periods define what was examined. Operator-task results are not direct measurements of long-term learning, dementia prevention or recovery from a different neurological condition.

Do not add the sample sizes of the paper’s components into a claimed number of unique volunteers without confirming whether participants overlapped. The source note below identifies which parts of the original report were available to check.

A stronger general conclusion would require a clearly specified outcome and a wider assessment of suitable studies, including contrary findings and methodological limitations. This short literature map does not perform that systematic assessment.

Use three separate questions when choosing further reading

A focused route through the references
Your questionStart with
Is the tested molecule Semax?The sequence and material description
Which molecular responses were observed after experimental ischaemia?The rat transcript and protein studies
What was measured in human volunteers?The original performance and EEG paper

These routes prevent a molecular mechanism paper from being used as if it were a clinical outcome trial. They also prevent a human paper’s title from supplying unmeasured claims about every use associated with Semax.

When recording a conclusion, name the study setting and endpoint before the direction of the result. That produces a useful, traceable research statement while leaving the next unanswered question explicit.

Sources and further detail

  1. Sudarkina and colleagues — Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion (opens in a new tab)

    Original 2021 abstract, sequence, author metadata and figure descriptions checked. Used for identity and a short tissue-specific protein result; the article title is not adopted as a general clinical conclusion.

  2. Medvedeva and colleagues — Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats (opens in a new tab)

    Original 2017 indexed abstract and author metadata checked. Brief Semax/PGP comparison only; no detailed expression dataset or experimental procedure reproduced.

  3. Kaplan and colleagues — Synthetic ACTH analogue Semax displays nootropic-like activity in humans (opens in a new tab)

    Original 1996 publisher abstract/metadata and author-uploaded paper methods read. Operator component size checked; no claim of 36 unique participants, modern replication or long-term clinical benefit. No administration instructions reproduced.

Sources checked 19 September 2026. Worked examples are illustrative unless a supplied report is explicitly identified. This article has not undergone independent scientific peer review.